Latest1 information on COVID-19

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Not Recruiting

Trial ID: NCT00185887

Age - 18 Years-N/A Condition - Neonatal and Developmental Medicine Gender - Female Accepting Healthy Volunteers - No

Purpose

To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation

Official Title

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Stanford Investigator(s)

Yasser El-Sayed, Professor
Yasser El-Sayed, Professor

Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery

Eligibility


Inclusion Criteria::

   - nonreassuring fetal heart rate tracing Exclusion Criteria:- maternal cardiac disease,
   placental abruption, intrauterine growth restriction, prior cesarean section

View More
View Less

Intervention(s):

drug: Terbutaline

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Yasser El-Sayed
6507233198

©2022 Stanford Medicine